The Importance of Country Selection in Clinical Study Design

Track:
Project/Portfolio Management and Strategic Planning

Day & Time:
June 27, 10:45AM - 12:15PM

Session Number:
420

Room Number:
152

Level:
Advanced

Type:
Session

Title:
The Importance of Country Selection in Clinical Study Design

Chair(s):
Joan M Meyer
Executive Director, Operational Strategy and Planning
Covance Inc., United States

Description:
The importance of country selection as part of the overall clinical trial strategy will be discussed. The impact of country selection on patient recruitment and retention programs and how it impacts a company’s marketing plans will be considered.

Learning Objective(s):
Discuss the importance of country selection in clinical study strategy and design; Describe the impact of country selection on patient recruitment and retention plans; Recognize the importance of proactively leveraging country selection to support marketing plan objectives.

Presentation(s) & Speaker(s):
Country-specific Differences in Data Quality and Clinical Grants Costs
Jeffrey S. Handen, PhD
Vice President, Clinical Solutions
Medidata Solutions Worldwide, United States

Panelist
Lani Hashimoto
Director, Strategic Development
MMG, United States